SA-1211

N/A

Report date: 2025/10/22 15:06:53
NME

Base Information

Drug NameSA-1211
Drug Alias NameSA-1211
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProgrammed cell death protein 1 inhibitorsHepatitis B virus inhibitors
TargetsProgrammed cell death protein 1Hepatitis B virus
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Siran Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Siran Biotechnology Co LtdBeijing Siyuan Rui'an Biotechnology Co LtdSuzhou Siran Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A